The University of Southampton
×
Filter your search:
University of Southampton Institutional Repository

Pembrolizumab in combination with axitinib for untreated advanced renal cell carcinoma: a Single Technology Appraisal

Pembrolizumab in combination with axitinib for untreated advanced renal cell carcinoma: a Single Technology Appraisal
Pembrolizumab in combination with axitinib for untreated advanced renal cell carcinoma: a Single Technology Appraisal
This report is a critique of the company’s submission (CS) to NICE from Merck Sharpe & Dohme on the clinical effectiveness and cost effectiveness of pembrolizumab in combination with axitinib for untreated advanced renal cell carcinoma. It identifies the strengths and weakness of the CS. Clinical experts were consulted to advise the ERG and to help inform this review.
HTA - NIHR127748
National Institute for Health and Care Research
Cooper, Keith
ea064f58-d71d-404a-bcf3-49d243b8825b
Loveman, E.
2cefe696-13ee-4d7c-9fc4-0cbddf6ab510
Onyimadu, Oluchukwu
ff168bd7-1c4f-4756-a34a-7e6b930ae29b
Scott, David Alexander
19b5fd34-9974-4ae4-8be0-27a693639e20
Colquitt, J.
17f508d0-72b6-49dd-af7b-1a19c38413f7
Shepherd, Jonathan
dfbca97a-9307-4eee-bdf7-e27bcb02bc67
Cooper, Keith
ea064f58-d71d-404a-bcf3-49d243b8825b
Loveman, E.
2cefe696-13ee-4d7c-9fc4-0cbddf6ab510
Onyimadu, Oluchukwu
ff168bd7-1c4f-4756-a34a-7e6b930ae29b
Scott, David Alexander
19b5fd34-9974-4ae4-8be0-27a693639e20
Colquitt, J.
17f508d0-72b6-49dd-af7b-1a19c38413f7
Shepherd, Jonathan
dfbca97a-9307-4eee-bdf7-e27bcb02bc67

Cooper, Keith, Loveman, E., Onyimadu, Oluchukwu, Scott, David Alexander, Colquitt, J. and Shepherd, Jonathan (2019) Pembrolizumab in combination with axitinib for untreated advanced renal cell carcinoma: a Single Technology Appraisal (Health Technology Assessment, HTA - NIHR127748) Southampton. National Institute for Health and Care Research 132pp.

Record type: Monograph (Project Report)

Abstract

This report is a critique of the company’s submission (CS) to NICE from Merck Sharpe & Dohme on the clinical effectiveness and cost effectiveness of pembrolizumab in combination with axitinib for untreated advanced renal cell carcinoma. It identifies the strengths and weakness of the CS. Clinical experts were consulted to advise the ERG and to help inform this review.

Text
Pembrolizumab with axitinib for untreated metastatic renal cell carcinoma - ERG report
Available under License Other.
Download (2MB)

More information

Published date: 25 September 2019
Related URLs:

Identifiers

Local EPrints ID: 441050
URI: http://eprints.soton.ac.uk/id/eprint/441050
PURE UUID: 0cd4cf89-69a6-45ee-a88b-6fd0e97d3f3b
ORCID for Keith Cooper: ORCID iD orcid.org/0000-0002-0318-7670
ORCID for Oluchukwu Onyimadu: ORCID iD orcid.org/0000-0002-1724-3485
ORCID for David Alexander Scott: ORCID iD orcid.org/0000-0001-6475-8046
ORCID for Jonathan Shepherd: ORCID iD orcid.org/0000-0003-1682-4330

Catalogue record

Date deposited: 28 May 2020 16:58
Last modified: 10 Apr 2024 02:03

Export record

Contributors

Author: Keith Cooper ORCID iD
Author: E. Loveman
Author: Oluchukwu Onyimadu ORCID iD
Author: David Alexander Scott ORCID iD
Author: J. Colquitt
Author: Jonathan Shepherd ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information
Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×